Related Research Articles
GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. It was purchased by Shire in 2013, with Shire paying around $4.2 billion for the company in a deal that was finalized in January 2014. ViroPharma was a member of the NASDAQ Biotechnology Index and the S&P 600.
Sir Philip Roy Hampton is a British businessman. He was the first chairman of UK Financial Investments Limited in 2008 and chairman of government-owned The Royal Bank of Scotland Group between 2009 and 2015. He has also chaired GlaxoSmithKline and J Sainsbury.
Smith, Kline & French (SKF) was an American pharmaceutical company.
Sir Andrew Philip Witty is a British business executive, who is the chief executive officer (CEO) of UnitedHealth Group. He was the CEO of GlaxoSmithKline between 2008 and 2017. He formerly held the role of chancellor of the University of Nottingham.
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan. Genmab is a dual-listed company with shares traded on both the Copenhagen Stock Exchange in Denmark and the NASDAQ Global Select Market in the US.
Cambridge Antibody Technology Group Plc, was a biotechnology company headquartered in Cambridge, England, United Kingdom. Its core focus was on antibody therapeutics, primarily using Phage Display and Ribosome Display technology.
Lynn Laverty Elsenhans is a businessperson who is the former chairperson, chief executive officer, and president of Sunoco.
Michelle Dipp is an American scientist, businesswoman, and investor. She is the co-founder and a managing partner at Biospring Partners and serves on the board of Abzena and Kiniciti.
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others.
The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.
Chris Viehbacher is a German-Canadian businessman. He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014. Viehbacher then worked with Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family.
Deirdre P. Connelly is a Puerto Rican business professional. Connelly is Chairman of the Board of the European Biotech company Genmab A/S, member of the Boards of Macy’s Inc. and the Lincoln Financial Group. Connelly was past President of North America Pharmaceuticals for GlaxoSmithKline from 2009-2015. Connelly is the first woman to hold that title, and one of only two women on GSK's corporate executive team. She is a member of the global Corporate Executive Team and co-chairs the Portfolio Management Board, along with the Chairman of Research and Development.
Dame Emma Natasha Walmsley is the chief executive officer (CEO) of GlaxoSmithKline. She succeeded Sir Andrew Witty, who retired in March 2017. Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. She grew up in Barrow-in-Furness, Cumbria, England.
Perry Nisen is an American physician and the former chief executive officer (CEO) of the Sanford Burnham Prebys Medical Discovery Institute (SBP). He was appointed as CEO in August 2014, and held the Donald Bren Chief Executive Chair.
Paul-Peter Tak M.D. PhD FMedSci is an immunologist and academic specialising in the fields of internal medicine, rheumatology and immunology. Tak has been the President & CEO of Candel Therapeutics since September 2020.
Namal Nawana is an Australian businessman, and former chief executive (CEO) of Smith & Nephew plc, a British multinational medical equipment manufacturing company.
Moncef Mohamed Slaoui is a Moroccan-born Belgian-American researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.
References
- ↑ "With great sadness we wish to inform you that Olivier Bohuon passed away on Sunday" . Retrieved 2024-05-07.
- 1 2 3 4 "BOHUON, Olivier Jean". Who's Who 2017. Oxford University Press. Retrieved 11 September 2017.
- ↑ "The business on...Olivier Bohuon, Chief executive, Smith & Nephew". The Independent. 5 November 2011. Retrieved 21 November 2012.
- ↑ "Namal Nawana appointed Chief Executive Officer of Smith & Nephew | Smith & Nephew". www.smith-nephew.com. Retrieved 2018-10-03.
- ↑ "Olivier Bohuon: Executive Profile". BusinessWeek. Retrieved 21 November 2012.[ dead link ]
- ↑ "Olivier Bohuon Elected to LEO Pharma's Board of Directors" . Retrieved 2018-10-03.
- ↑ Brown, John Murray (February 1, 2016). "Smith & Nephew chief Olivier Bohuon has 'highly treatable' cancer". Financial Times. Retrieved 11 September 2017.
- ↑ Bradshaw, Julia (1 February 2016). "Smith & Nephew boss reveals cancer diagnosis". The Daily Telegraph. Retrieved 11 September 2017.
- ↑ "FN20240508-Mourning the passing of Olivier Bohuon". www.smith-nephew.com.
 | This French business–related biographical article is a stub. You can help Wikipedia by expanding it. |